Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 2 1

Status

Completed 53Unknown 13Terminated 11Recruiting 11Active not recruiting 9Withdrawn 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 1Infratentorial Neoplasms 1Arnold-Chiari Malformation 1Acetaminophen Exposure 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Acetaminophen × Clear all
NCT05013437 2024-04-02

AHCT

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Withdrawn
Plasma cell

Multiple Myeloma

NCT02911961 2021-09-02

APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors

Denver Health and Hospital Authority

Phase 4 Withdrawn

Acetaminophen Exposure

NCT02532322 2021-04-08

Efficacy of Acetaminophen in Posterior Fossa Surgery

Children's National Research Institute

Phase 2 Withdrawn

Arnold-Chiari Malformation, Infratentorial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡